{"id":"https://openalex.org/W2789736310","doi":"https://doi.org/10.1200/jco.2018.36.6_suppl.205","title":"Onset and maintenance of testosterone suppression in four pivotal trials of subcutaneously administered leuprolide acetate formulated with in-situ forming polymeric delivery technology.","display_name":"Onset and maintenance of testosterone suppression in four pivotal trials of subcutaneously administered leuprolide acetate formulated with in-situ forming polymeric delivery technology.","publication_year":2018,"publication_date":"2018-02-20","ids":{"openalex":"https://openalex.org/W2789736310","doi":"https://doi.org/10.1200/jco.2018.36.6_suppl.205","mag":"2789736310"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.6_suppl.205","doi":"https://doi.org/10.1200/jco.2018.36.6_suppl.205","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.6_suppl.205","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108786021","display_name":"Przemyslaw W. Twardowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104056","display_name":"Saint John's Health Center","ror":"https://ror.org/01gcc9p15","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104056","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Przemyslaw Twardowski","raw_affiliation_strings":["John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA;","institution_ids":["https://openalex.org/I4210104056"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056236802","display_name":"John A. McLane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158539","display_name":"Tolmar (United States)","ror":"https://ror.org/05dpb2x88","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158539"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John A. McLane","raw_affiliation_strings":["TOLMAR, Inc., Fort Collins, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TOLMAR, Inc., Fort Collins, CO;","institution_ids":["https://openalex.org/I4210158539"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021757130","display_name":"Stuart N. Atkinson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stuart Atkinson","raw_affiliation_strings":["TOLMAR, Inc., Lincolnshire, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TOLMAR, Inc., Lincolnshire, IL;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109389898","display_name":"Debbie Boldt-Houle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Debbie Boldt-Houle","raw_affiliation_strings":["TOLMAR, Inc., Lincolnshire, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TOLMAR, Inc., Lincolnshire, IL;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073246821","display_name":"Oliver A. Sartor","orcid":"https://orcid.org/0000-0002-8777-7343","observed_orcids":["https://orcid.org/0000-0002-8777-7343"]},"institutions":[{"id":"https://openalex.org/I114832834","display_name":"Tulane University","ror":"https://ror.org/04vmvtb21","country_code":"US","type":"education","lineage":["https://openalex.org/I114832834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Oliver Sartor","raw_affiliation_strings":["Tulane University School of Medicine, New Orleans, LA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tulane University School of Medicine, New Orleans, LA;","institution_ids":["https://openalex.org/I114832834"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"6_suppl","first_page":"205","last_page":"205"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11146","display_name":"Hormonal and reproductive studies","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/leuprolide-acetate","display_name":"leuprolide","score":0.9810000061988831},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.9539999961853027},{"id":"https://openalex.org/keywords/testosterone-suppression","display_name":"testosterone suppression","score":0.9670000076293945},{"id":"https://openalex.org/keywords/medical-castration","display_name":"medical castration","score":0.8460000157356262},{"id":"https://openalex.org/keywords/advanced-prostate-cancer","display_name":"advanced prostate cancer","score":0.9390000104904175},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.6629999876022339},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.5429999828338623},{"id":"https://openalex.org/keywords/disease-specific-survival","display_name":"disease-specific survival","score":0.5889999866485596},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.8610000014305115},{"id":"https://openalex.org/keywords/fixed-dose-regimen","display_name":"fixed-dose regimen","score":0.4399999976158142}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8844115138053894},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6338939666748047},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5370923280715942},{"id":"https://openalex.org/C2779279991","wikidata":"https://www.wikidata.org/wiki/Q6058681","display_name":"Testosterone (patch)","level":2,"score":0.5342077016830444},{"id":"https://openalex.org/C2779256933","wikidata":"https://www.wikidata.org/wiki/Q58929","display_name":"Castration","level":3,"score":0.4814271628856659},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.47240132093429565},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44368258118629456},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2973647713661194},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.14284569025039673},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.6_suppl.205","doi":"https://doi.org/10.1200/jco.2018.36.6_suppl.205","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.6_suppl.205","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2598338561","https://openalex.org/W2790697985","https://openalex.org/W2605048906","https://openalex.org/W2414101905","https://openalex.org/W2338234116","https://openalex.org/W1684260988","https://openalex.org/W2794229636","https://openalex.org/W4408960699","https://openalex.org/W2921825512","https://openalex.org/W2946333767"],"abstract_inverted_index":{"205":[0],"Background:":[1],"Subcutaneously":[2],"administered":[3],"leuprolide":[4],"acetate":[5],"(SC-LA)":[6],"formulated":[7],"with":[8,30,50,75,260],"in-situ":[9],"forming":[10],"polymeric":[11],"delivery":[12],"technology":[13],"has":[14],"demonstrated":[15],"efficacy":[16],"in":[17,28,105,242,246,251],"suppressing":[18],"testosterone":[19],"(T)":[20],"levels":[21,69,113,132],"to":[22,61,292],"achieve":[23],"and":[24,40,48,65,121,136,175,190,197,230,249,264,274,289],"maintain":[25],"medical":[26],"castration":[27,74],"patients":[29,81,214],"advanced":[31],"prostate":[32],"cancer":[33],"(PCa).":[34],"Increasing":[35],"evidence":[36],"suggests":[37],"that":[38,213],"reaching":[39],"sustaining":[41],"the":[42,63,128,148,180,202,208,267],"lowest":[43],"T":[44,68,112,131,141,152,158,174,187,204,216,258,279],"possible":[45],"is":[46],"desirable":[47],"correlated":[49],"disease":[51,293],"specific":[52],"survival.":[53],"Data":[54],"was":[55,145,206,222],"pooled":[56,181],"from":[57],"four":[58],"pivotal":[59,109],"trials":[60],"determine":[62],"onset":[64,185,239],"maintenance":[66],"of":[67,95,186,211,240,266],"at":[70,116,122],"or":[71,101],"lower":[72],"than":[73],"SC-LA":[76,96,236,254],"treatment.":[77],"Methods:":[78],"Eugonadal":[79],"PCa":[80],"received":[82],"either":[83],"7.5":[84],"(6":[85],"doses),":[86],"22.5,":[87],"30,":[88],"45":[89],"mg":[90],"(2":[91],"doses":[92],"each)":[93],"injections":[94],"lasting":[97],"1,":[98],"3,":[99],"4,":[100],"6":[102],"months,":[103],"respectively,":[104],"4":[106,247],"open-label,":[107],"fixed-dose,":[108],"trials.":[110],"Serum":[111],"were":[114,133,192],"assessed":[115],"screening,":[117],"baseline":[118],"(Day":[119],"0),":[120],"least":[123],"once":[124],"per":[125],"week":[126],"throughout":[127],"studies.":[129],"Target":[130],"50,":[134],"20,":[135,273],"10ng/dL.":[137],"The":[138],"time":[139,212,291],"when":[140],"crossed":[142],"target":[143,173,203,220],"level":[144,205,221],"extrapolated":[146],"using":[147],"following":[149],"formula:":[150],"(target":[151],"\u2013":[153,159,165],"post-target":[154,160,176],"T)":[155,161],"/":[156],"(pre-target":[157],"x":[162],"(post-target":[163],"date":[164],"pre-target":[166],"date)":[167],"=":[168],"estimated":[169],"days":[170],"between":[171],"crossing":[172],"measurement":[177],"Results:":[178],"In":[179],"population":[182],"(N=437),":[183],"median":[184],"\u226450,":[188],"\u226420,":[189],"\u226410ng/dL":[191],"21":[193],"days,":[194,196,199],"28":[195],"35":[198],"respectively.":[200,277],"Once":[201],"achieved,":[207],"mean":[209],"proportion":[210],"maintained":[215,255],"suppression":[217,280],"below":[218,271],"each":[219],"100%":[223,265],"for":[224,228,232,285],"T\u226450":[225],"ng/dL,":[226],"94-99%":[227],"T\u226420ng/dL,":[229],"66-85%":[231],"T\u226410ng/dL":[233,250],"(Table).":[234],"Conclusions:":[235],"achieved":[237],"rapid":[238],"T\u226450ng/dL":[241],"3":[243],"weeks,":[244,248],"T\u226420ng/dL":[245],"5":[252],"weeks.":[253],"consistently":[256],"low":[257],"levels,":[259],"over":[261],"66%,":[262],"95%,":[263],"treatment":[268],"period":[269],"remaining":[270],"10,":[272],"50":[275],"ng/dL":[276],"This":[278],"profile":[281],"may":[282],"have":[283],"relevance":[284],"improved":[286],"patient":[287],"survival":[288],"extended":[290],"progression.":[294],"[Table:":[295],"see":[296],"text]":[297]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2018-03-29T00:00:00"}